| Product Code: ETC13208421 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Cannabis Pharmaceutical Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Cannabis Pharmaceutical Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 North America Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 North America Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 North America Cannabis Pharmaceutical Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 North America Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 North America Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.9 North America Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 North America Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 North America Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Cannabis Pharmaceutical Market Trends |
6 North America Cannabis Pharmaceutical Market, 2021 - 2031 |
6.1 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Capsules, 2021 - 2031 |
6.1.3 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Concentrates, 2021 - 2031 |
6.1.4 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Edibles, 2021 - 2031 |
6.2 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Epidiolex, 2021 - 2031 |
6.2.3 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Marinol, 2021 - 2031 |
6.2.4 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Cesamet, 2021 - 2031 |
6.2.5 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Sativex, 2021 - 2031 |
6.3 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Tetrahydrocannabinol (THC), 2021 - 2031 |
6.3.3 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Cannabidiol (CBD), 2021 - 2031 |
6.3.4 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Balanced THC & CBD, 2021 - 2031 |
6.4 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Inflammation, 2021 - 2031 |
6.4.3 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Chronic Pain, 2021 - 2031 |
6.4.4 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Epilepsy, 2021 - 2031 |
6.4.5 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Sleep Disorders, 2021 - 2031 |
6.4.6 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Anorexia, 2021 - 2031 |
6.4.7 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Schizophrenia, 2021 - 2031 |
6.5 North America Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Clinic, 2021 - 2031 |
6.5.3 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.6 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.6.3 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.6.4 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 North America Cannabis Pharmaceutical Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.1 United States (US) Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.2 Canada Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.3 Rest of North America Cannabis Pharmaceutical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3 North America Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
7.3.1 United States (US) Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.3.2 Canada Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.3.3 Rest of North America Cannabis Pharmaceutical Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.4 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
7.4.1 United States (US) Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
7.4.2 Canada Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
7.4.3 Rest of North America Cannabis Pharmaceutical Market, Revenues & Volume, By Compound Type, 2021 - 2031 |
7.5 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.1 United States (US) Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.2 Canada Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.3 Rest of North America Cannabis Pharmaceutical Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.1 United States (US) Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.2 Canada Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.3 Rest of North America Cannabis Pharmaceutical Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7 North America Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.1 United States (US) Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.2 Canada Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.3 Rest of North America Cannabis Pharmaceutical Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Cannabis Pharmaceutical Market Key Performance Indicators |
9 North America Cannabis Pharmaceutical Market - Export/Import By Countries Assessment |
10 North America Cannabis Pharmaceutical Market - Opportunity Assessment |
10.1 North America Cannabis Pharmaceutical Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.3 North America Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10.4 North America Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
10.5 North America Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
10.6 North America Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10.7 North America Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Cannabis Pharmaceutical Market - Competitive Landscape |
11.1 North America Cannabis Pharmaceutical Market Revenue Share, By Companies, 2022 |
11.2 North America Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here